Side-by-side comparison
NVS vs SYK — Side-by-side comparison
SYK screens cheaper on EV/FCF, SYK has the higher ROIC, SYK has grown revenue faster over five years, and SYK has the cleaner balance sheet by net debt / EBITDA.
NVS
Novartis AG
Price
$152.01
Market cap
$223.3B
Day %
N/A
SYK
Stryker Corp.
Price
$316.48
Market cap
$145.6B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
NVS implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
SYK implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
33.0x
FCF yield
2.9%
5Y rev CAGR
11.8%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for NVS.
Grade F
0
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for SYK.
Grade B
72
/ 100
Quality Radar0 – 20 per axis